Question 1

Is Sumatriptan currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Sumatriptan has 49 active shortage notices across 8 countries (Belgium, Netherlands, New Zealand, Italy, Canada, Bosnia and Herzegovina and more). Status is refreshed daily from official regulatory sources.

Question 2

Why is Sumatriptan in shortage?

Accepted Answer

Regulators attribute the current Sumatriptan shortages to manufacturing problems, unexpected increases in demand, supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Sumatriptan shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 5 Jun 2026 to 11 Aug 2027, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

Where does this Sumatriptan shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
Belgium	high	29	19 Feb 2026	11 Aug 2027	FAMHP
Netherlands	high	12	30 Mar 2026	—	CBG-MEB

Sumatriptan shortage status

Where Sumatriptan is in shortage

Why Sumatriptan is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Sumatriptan status changes